Source: http://health.yahoo.net/news/s/nm/biolinerx-patent-protection-extended-for-schizophrenia-drug
Monday, 24 September 2012
BioLineRx patent protection extended for schizophrenia drug
TEL AVIV (Reuters) - Israeli biopharmaceutical development firm BioLineRx received a new patent from the U.S. Patent and Trademark Office for BL-1020, an experimental schizophrenia treatment. The patent will be valid at least until 2031, extending...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.